A peer reviewed article discusses the use of convalescent plasma, i.e. passive polyclonal antibody (Ab) for treatment of COVID-19, as an effective, safe and successful treatment for COVID-19.
The article also outlines a brief methodology for treatment using convalescent plasma drawing upon the experience in France.
Tiberghien, P., de Lambalerie, X., Morel, P., Gallian, P., Lacombe, K. and Yazdanpanah, Y. (2020), Collecting and evaluating convalescent plasma for COVID‐19 treatment: why and how. Vox Sang. Accepted Author Manuscript. doi:10.1111/vox.12926